1. Home
  2. Analysis
  3. Opana-er
  4. Staphylococcal-infection

Opana er and Staphylococcal infection - a phase IV clinical study of FDA data

Summary:

Staphylococcal infection is reported as a side effect among people who take Opana er (oxymorphone hydrochloride), especially for people who are male, 20-29 old, also take Cipro, and have Immunodeficiency common variable.

The phase IV clinical study analyzes which people have Staphylococcal infection when taking Opana er. It is created by eHealthMe based on reports of 33,673 people who have side effects when taking Opana er from the FDA, and is updated regularly.

What is Opana er?

Opana er has active ingredients of oxymorphone hydrochloride. It is often used in pain. eHealthMe is studying from 33,986 Opana er users. Check the latest studies of Opana er.

What is Staphylococcal infection?

Staphylococcal infection (an infection with staphylococcus bacteria) is found to be associated with 1,724 drugs and 1,898 conditions by eHealthMe. Check the latest studies of Staphylococcal infection.

On Jul, 11, 2026

33,673 people reported to have side effects when taking Opana er.
Among them, 39 people (0.12%) have Staphylococcal infection.

Could Opana er cause Staphylococcal infection?

Among these 39 people:

What is the gender of people who have Staphylococcal infection when taking Opana er? *

  • female: 48.65 %
  • male: 51.35 %

What is the age of people who have Staphylococcal infection when taking Opana er? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 42.86 %
  • 30-39: 34.29 %
  • 40-49: 14.29 %
  • 50-59: 8.57 %
  • 60+: 0.0 %

What are other drugs people take besides Opana er? *

  1. Xanax: 1 person, 2.56%
  2. Tegretol: 1 person, 2.56%
  3. Soma: 1 person, 2.56%
  4. Prozac: 1 person, 2.56%
  5. Neurontin: 1 person, 2.56%
  6. Hizentra: 1 person, 2.56%
  7. Flagyl: 1 person, 2.56%
  8. Epipen: 1 person, 2.56%
  9. Cipro: 1 person, 2.56%

What are other side effects people have besides Staphylococcal infection? *

  1. Staphylococcal Bacteraemia (a bacterial infection of blood): 32 people, 82.05%
  2. Endocarditis (inflammation in heart muscle): 27 people, 69.23%
  3. Septic Shock (shock due to blood infection): 21 people, 53.85%
  4. Respiratory Acidosis (respiratory failure or ventilatory failure, causes the ph of blood and other bodily fluids to decrease): 20 people, 51.28%
  5. Injection Site Abscess: 18 people, 46.15%
  6. Injection Site Cellulitis (injection site inflammation): 14 people, 35.90%
  7. Osteomyelitis (infection of bone): 5 people, 12.82%
  8. Sepsis (a severe blood infection that can lead to organ failure and death): 4 people, 10.26%
  9. Overdose: 3 people, 7.69%
  10. Microangiopathic Haemolytic Anaemia (anaemia due to inability of bone marrow to compensate the premature destruction of red blood cells): 2 people, 5.13%

What are the existing conditions these people have? *

  1. Immunodeficiency Common Variable: 1 person, 2.56%

* Approximation only. Some reports may have incomplete information.

Do you take Opana er and have Staphylococcal infection?

- Check whether Staphylococcal infection is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Opana er:

Staphylococcal infection treatments and more:

How severe was Staphylococcal infection and when was it recovered:

Expand to all the drugs that have ingredients of oxymorphone hydrochloride:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Opana er:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Staphylococcal infection:

Browse all the conditions that are associated with Staphylococcal infection:

How the study uses the data?

The study uses data from the FDA. It is based on oxymorphone hydrochloride (the active ingredients of Opana er) and Opana er (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.